Skip to main content
Delic Holdings Corp. logo

Delic Holdings Corp. — Investor Relations & Filings

Ticker · DELCF ISIN · CA24689E1079 LEI · 8945004HTB9451S6LV82 CSE Human health and social work activities
Open in API
Filings indexed 264 across all filing types
Latest filing 2021-07-06 Regulatory Filings
Country CA Canada
Listing CSE DELCF

About Delic Holdings Corp.

https://thedelic.com

Delic Holdings Corp. is a psychedelic wellness corporation committed to delivering safe, legal, and science-backed benefits. The company operates an integrated ecosystem spanning media, science, and health services. Its core business involves owning and operating a chain of psychedelic wellness clinics, establishing one of the largest infrastructures in the sector. Delic provides various medicines and treatments, aiming to improve access to health benefits. Additionally, the company focuses on developing intellectual property and manages "The Delic," a creative platform dedicated to reframing the public conversation surrounding new medicines and treatments.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2021-07-06 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing a partnership agreement between DELIC Labs and Agilent Technologies. It contains no financial statements, no regulatory filings, no voting results, no management changes, no earnings data, and no detailed financial or operational reports. It is a corporate announcement about a business partnership and marketing collaboration. The document length is 8670 characters, which is relatively short and typical for a press release. There is no indication that this is a report or filing required by a regulatory body, nor does it contain any financial data or analysis. Therefore, it does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. The best fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2021-06-30 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the rebranding of Complex Biotech Discovery Ventures Ltd. (CBDV) as DELIC Labs, describing the company's business focus, recent acquisition highlights, management expertise, and forward-looking statements. It does not contain any financial statements, detailed financial performance data, or regulatory filings such as annual or quarterly reports. It is primarily a corporate announcement about branding and business strategy, not a financial report or regulatory filing. The document length is over 12,000 characters, but it is clearly a news release rather than a report or filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous corporate announcements and press releases that do not fit other specific categories.
2021-06-29 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing an upcoming event called 'Meet DELIC,' which is described as a psychedelic and wellness edutainment event and expo. It includes details about the event dates, location, speakers, and the company's business focus. There is no financial data, regulatory filing, or report content such as annual or quarterly financial statements. The document is promotional and informational about a corporate event rather than a financial or regulatory filing. It does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. It is also not a report publication announcement since it does not mention the release or availability of a report. Therefore, the best fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2021-06-25 English
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'FORM 51-102F3 MATERIAL CHANGE REPORT' and details a material change event involving the acquisition of Ketamine Infusion Centers LLC by Delic Holdings Inc. It includes specifics about the transaction terms, milestone payments, and forward-looking statements. The form number 51-102F3 is a Canadian regulatory filing used to report material changes by a company. The content focuses on a significant corporate event (an acquisition) rather than a full financial report, earnings release, or management discussion. It is not an annual or interim report, nor is it a call transcript or governance document. The document is a formal announcement of a material change event, which aligns with the category of Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories. The document length (9,340 characters) and detailed content confirm it is not a brief announcement or a report publication notice. Therefore, the best classification is Regulatory Filings (RNS).
2021-06-15 English
News release - English.pdf
M&A Activity Classification · 95% confidence The document is a press release announcing that Delic Holdings Inc. has signed a definitive agreement to acquire Ketamine Infusion Centers LLC. It details the terms of the acquisition, transaction highlights, and forward-looking statements. There are no financial statements, quarterly or annual results, or detailed management discussion of financial performance. The document is primarily an announcement of a merger/acquisition transaction, not a full merger filing or proxy statement. It fits best under the category of M&A Activity (TAR) as it announces and describes a merger/acquisition agreement.
2021-06-08 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.